Selecta Biosciences Inc.

NASDAQ: SELB · Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM

Selecta Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
38.91M n/a 110.78M 85.08M
Cost of Revenue
n/a n/a 72.38M 68.74M
Gross Profit
n/a n/a 38.4M 16.34M
Operating Income
n/a -86.42M 14.54M -4.6M
Interest Income
7.39M n/a 958K 2.8M
Pretax Income
-77.14M -238.71M 34.77M -9.72M
Net Income
-77.42M -219.71M 35.38M -25.69M
Selling & General & Admin
30.13M 40.58M 23.86M 20.94M
Research & Development
45.1M 71.84M 72.38M 68.74M
Other Expenses
7.58M n/a 330K 15K
Operating Expenses
82.81M 112.42M 96.24M 89.67M
Interest Expense
n/a -2.83M 3.03M 2.84M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 112.42M 96.24M 89.67M
Income Tax Expense
-287K 19M -609K 15.97M
Shares Outstanding (Basic)
155.11M 154.96M 144.76M 114.33M
Shares Outstanding (Diluted)
155.11M 154.96M 145.87M 114.33M
EPS (Basic)
-0.5 -1.42 0.24 -0.22
EPS (Diluted)
-0.5 -1.42 0.24 -0.22
EBITDA
n/a -86.42M 16.16M -4.58M
EBIT
n/a -241.54M 37.8M -6.88M
Depreciation & Amortization
n/a 764K 1.62M 15K